Related Experiment Video
Updated: Jan 20, 2026

An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
Published on: June 7, 2015
An Injectable Click-Crosslinked Hydrogel that Prolongs Dexamethasone Release from Dexamethasone-Loaded Microspheres
Ji Yeon Heo1, Jung Hyun Noh1, Seung Hun Park1
1Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea.
Injectable dexamethasone microspheres (Dex-Ms) combined with click-crosslinked hyaluronic acid (Cx-HA) hydrogels provide sustained drug release for 28 days. This novel formulation offers prolonged therapeutic dexamethasone levels via a minimally invasive injectable drug depot.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Nanotechnology
Background:
- Sustained drug delivery is crucial for effective therapeutic outcomes, reducing dosing frequency and improving patient compliance.
- Injectable hydrogels offer a minimally invasive approach for localized drug delivery, forming depots in situ.
- Hyaluronic acid (HA) is a biocompatible polymer with potential for creating advanced drug delivery matrices.
Purpose of the Study:
- To evaluate the prolonged therapeutic effect of injectable dexamethasone-loaded microspheres (Dex-Ms) formulated with click-crosslinked hyaluronic acid (Cx-HA) hydrogels.
- To compare the in vivo performance of Dex-Ms/Cx-HA with Dex-Ms/Pluronic (PH) and Dex-Ms alone for sustained dexamethasone release.
Main Methods:
- Dexamethasone-loaded microspheres (Dex-Ms) were prepared using ultrasonic atomization.
- Click-crosslinked hyaluronic acid (Cx-HA) was synthesized via click chemistry between TCO-HA and TET-HA.
- Injectable formulations (Dex-Ms/PH and Dex-Ms/Cx-HA) were prepared and tested in Sprague Dawley rats, with drug release monitored in vitro and in vivo.
Main Results:
- The Cx-HA hydrogel demonstrated in vivo persistence for 28 days, significantly longer than the PH hydrogel (6 days).
- Dex-Ms/Cx-HA exhibited significantly slower initial drug release, followed by sustained dexamethasone release over 28 days.
- The Cx-HA hydrogel acted as an external matrix, retarding Dex release from the microspheres, creating an effective drug depot.
Conclusions:
- Injectable Dex-Ms encapsulated within a Cx-HA hydrogel create a minimally invasive drug depot for extended in vivo dexamethasone delivery.
- The Dex-Ms/Cx-HA formulation significantly prolongs therapeutic dexamethasone levels compared to control formulations.
- This injectable click-crosslinked HA hydrogel system shows excellent potential for sustained drug delivery applications.
Related Concept Videos
10:28An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
08:59A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
09:06Preparation of DNA-crosslinked Polyacrylamide Hydrogels
09:29Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds
06:35Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
09:19Intramyocardial Transplantation of MSC-Loading Injectable Hydrogels after Myocardial Infarction in a Murine Model

